About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
MitoQ
- Company
- Duke University
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 10 recruiting
Efficacy results: Not yet reported
10 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 28, 2026
Find a Clinical Trial Near Me
See recruiting studies for MitoQ and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02966665
: Vascular Function in Health and Disease
Not yet reported D. Walter Wray 420 participants Est. completion 2030-08 1 site Stand-aloneHeart failure Other conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, HypertensionView official trial listing → -
Recruiting NCT NCT05373043
Long-term COVID and Rehabilitation
Not yet reported VA Office of Research and Development 300 participants Est. completion 2028-10-31 1 siteOther conditions: Long-COVIDView official trial listing → -
Recruiting NCT NCT06027554
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Not yet reported UConn Health 60 participants Est. completion 2028-02-01 1 site Stand-aloneOther conditions: Frailty, Mild Cognitive Impairment, AgingView official trial listing → -
Recruiting NCT NCT06191965
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Not yet reported, Not yet reported Mclean Hospital 100 participants Est. completion 2027-01-31 3 sites Stand-aloneOther conditions: Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive ImpairmentView official trial listing → -
Recruiting NCT NCT06409949
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
Not yet reported University of Nebraska 60 participants Est. completion 2027-06 1 siteOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Recruiting NCT NCT06424756
Effects of an Antioxidant Supplement on Blood Vessel Health
Not yet reported University of Georgia 60 participants Est. completion 2030-03-31 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT06930638
MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes
Not yet reported Medical College of Wisconsin 30 participants Est. completion 2026-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07142096
WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
Not yet reported Université Catholique de Louvain 20 participants Est. completion 2026-07-20 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07229261
MitoQ to Improve Vascular Funciton in Preeclampsia
Not yet reported Medical College of Wisconsin 80 participants Est. completion 2027-09-30 1 site Stand-aloneOther conditions: Preeclampsia, PregnancyView official trial listing → -
Recruiting NCT NCT07244809
Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adversity
Not yet reported University of Iowa 300 participants Est. completion 2026-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Adverse Childhood Experience, Endothelial Function (FMD), Endothelial Injury, Mitochondrial Function, Oxidative StressView official trial listing → -
Completed NCT NCT00329056
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
Not yet reported Antipodean Pharmaceuticals, Inc. 128 participants Est. completion 2007-11 13 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00433108
Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
Not yet reported Antipodean Pharmaceuticals, Inc. 30 participants Est. completion 2007-11 2 sitesOther conditions: Chronic Hepatitis CView official trial listing → -
Terminated NCT NCT01167088
A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
Not yet reported Antipodean Pharmaceuticals, Inc. 110 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Status unknown NCT NCT02364648
Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
Not yet reported University of Delaware 24 participants Est. completion 2019-09-30 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT02597023
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
Not yet reported University of Colorado, Boulder 55 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: AgingView official trial listing → -
Active, not recruiting NCT NCT02690064
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF
Not yet reported Augusta University 13 participants Est. completion 2027-01 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Terminated NCT NCT03166800
MitoQ for Fatigue in Multiple Sclerosis
Not yet reported, Not yet reported Oregon Health and Science University 9 participants Est. completion 2019-01-10 1 siteOther conditions: Multiple Sclerosis, FatigueView official trial listing → -
Completed NCT NCT03506633
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
Not yet reported University of Nebraska 14 participants Est. completion 2022-01-17 1 site Stand-aloneOther conditions: Peripheral Arterial Disease, Peripheral Artery DiseaseView official trial listing → -
Withdrawn NCT NCT03514875
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
Not yet reported University of Nebraska Est. completion 2022-07-18 Stand-aloneOther conditions: Alzheimer Disease, Early Onset, Mild Cognitive ImpairmentView official trial listing → -
Active, not recruiting NCT NCT03586414
MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women
Not yet reported University of Colorado, Denver 31 participants Est. completion 2030-08 1 siteOther conditions: Diastolic DysfunctionView official trial listing → -
Completed NCT NCT03960073
Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction
Not yet reported Virginia Commonwealth University 25 participants Est. completion 2022-09-30 1 site Stand-aloneHeart failure Other conditions: Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT04026711
MitoQ for the Treatment of Metabolic Dysfunction in Asthma
Not yet reported University of Vermont 47 participants Est. completion 2024-03-31 2 sitesOther conditions: Asthma, ObesityView official trial listing → -
Status unknown NCT NCT04098510
Concentration of MitoQ in Human Skeletal Muscle
Not yet reported University of Copenhagen 10 participants Est. completion 2020-09-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04109820
Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
Not yet reported University of Pittsburgh 18 participants Est. completion 2025-06-30 5 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT04267926
MitoQ for Fatigue in Multiple Sclerosis (MS)
Not yet reported, Not yet reported VA Office of Research and Development 45 participants Est. completion 2026-03-31 1 siteOther conditions: Multiple Sclerosis, FatigueView official trial listing → -
Active, not recruiting NCT NCT04276740
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
Not yet reported University of Edinburgh 79 participants Est. completion 2026-11-30 1 siteOther conditions: Ulcerative Colitis FlareView official trial listing → -
Status unknown NCT NCT04334135
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
Not yet reported Auburn University 60 participants Est. completion 2025-08-31 1 site Stand-aloneOther conditions: Racial Disparities, Blood Pressure, Cardiovascular Risk Factor, Renal FunctionView official trial listing → -
Completed NCT NCT04558190
Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
Not yet reported University of Copenhagen 10 participants Est. completion 2021-11-01 1 site Stand-aloneOther conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT04851288
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Not yet reported University of Colorado, Boulder 112 participants Est. completion 2026-07-31 1 site Stand-aloneOther conditions: AgingView official trial listing → -
Status unknown NCT NCT05146843
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
Not yet reported D'Or Institute for Research and Education 44 participants Est. completion 2023-12-02 Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT05381454
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
Not yet reported, Not yet reported University of California, Los Angeles 80 participants Est. completion 2023-05-09 1 site Stand-aloneOther conditions: Respiratory Viral Infection, Antiviral Treatment, COVID-19View official trial listing → -
Completed NCT NCT05410873
Examining the Effects of Mitochondrial Oxidative Stress in DCM
Not yet reported Imperial College London 53 participants Est. completion 2024-06-19 1 site Stand-aloneOther conditions: Dilated CardiomyopathyView official trial listing → -
Withdrawn NCT NCT05539625
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
Not yet reported University of Edinburgh Est. completion 2026-10-31 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT05561556
Mitochondria Oxidative Stress and Vascular Health Study
Not yet reported Auburn University 31 participants Est. completion 2025-09-26 1 site Stand-aloneCardiovascular disease Other conditions: Hypertension, Racism, Vascular DiseasesView official trial listing → -
Terminated NCT NCT05605548
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
Not yet reported Virginia Commonwealth University 4 participants Est. completion 2024-07-30 1 site Stand-aloneOther conditions: Chronic Obstructive Pulmonary DiseaseView official trial listing → -
Active, not recruiting NCT NCT05686967
MitoQ and Exercise Effects on Vascular Health
Not yet reported University of Colorado, Denver 22 participants Est. completion 2025-11-30 1 site Stand-aloneOther conditions: Aging, MenopauseView official trial listing → -
Completed NCT NCT05872139
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
Not yet reported Ball State University 23 participants Est. completion 2023-05-01 1 site Stand-aloneOther conditions: Aging, Endothelial Dysfunction, Cardiovascular Function, Arterial StiffnessView official trial listing → -
Completed NCT NCT05886816
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
Not yet reported University of Texas Southwestern Medical Center 122 participants Est. completion 2026-06-01 1 site Stand-aloneOther conditions: SARS-CoV Infection, COVID-19View official trial listing → -
Completed NCT NCT06069245
MitoQ & Cardiopulmonary Responses During Exercise
Not yet reported Ball State University 9 participants Est. completion 2023-04-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT06351683
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Not yet reported Iman Al-Naggar, PhD 20 participants Est. completion 2026-04-01 1 site Stand-aloneOther conditions: Lower Urinary Tract Symptoms, Overactive Bladder SyndromeView official trial listing → -
Completed NCT NCT06429059
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
Not yet reported Duke University 50 participants Est. completion 2025-06-24 2 sites Stand-aloneOther conditions: Amyotrophic Lateral Sclerosis ALSView official trial listing → -
Completed NCT NCT06784531
The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold
Not yet reported United States Army Research Institute of Environmental Medicine 26 participants Est. completion 2025-10-28 1 site Stand-aloneOther conditions: Cold ExposureView official trial listing → -
Not yet recruiting NCT NCT07228208
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
Not yet reported Medical College of Wisconsin 40 participants Est. completion 2031-12-31 1 site Stand-aloneType 2 diabetes Other conditions: Endothelial DysfunctionView official trial listing → -
Not yet recruiting NCT NCT07406243
Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal Women
Not yet reported Colorado State University 86 participants Est. completion 2030-07 1 site Stand-aloneOther conditions: Aging, PostmenopauseView official trial listing → -
Not yet recruiting NCT NCT07836777
Efficacy and Safety of MitoQ in Improving Cancer Cachexia
Not yet reported The First Affiliated Hospital of Xinxiang Medical College 20 participants Est. completion 2027-06-01 Stand-aloneOther conditions: Cancer Cachexia (CC), Cancer Patients With Solid TumorsView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.